Genetic studies on psoriasis with emphasis on the HLA-region. ISBN
|
|
- Angelica Gaines
- 8 years ago
- Views:
Transcription
1 PUBLICATION LIST A. Thesis Genetic studies on psoriasis with emphasis on the HLA-region. ISBN Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Evidence that HLA-Cw6 determines early onset of psoriasis- obtained using sequence-specific-primers (PCR-SSP). Acta Derm Venereol 1997; 77: Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Samuelsson L, Swanbeck G. Significantly earlier age at onset for the HLA-Cw6 positive than for the Cw6 negative psoriatic sibling. J Invest Dermatol 1997; 22: Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson Å, Martinsson T and Swanbeck G. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families; confirmation of linkage to chromosome 6p (HLA-region), and to 17q, but not to 4q. Human Heredity 1999; 49: Enerbäck C, Enlund F, Inerot A, Samuelsson L, Wahlström J, Swanbeck G, Martinsson T. S gene (corneodesmosin) diversity and its relationship to psoriasis; high content of csnps in the HLA-linked S gene. J Invest Dermatol 2000; 114: Enerbäck C, Enlund F, Inerot A, Samuelsson L, Wahlström J, Swanbeck G, Martinsson T Stronger association to HLA-Cw6 than to corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch Dermatol Res. 2000; 292: Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G, Martinsson T. Cytogenetic analysis of 477 psoriatics revealed an increased frequency of aberrations involving chromosome region 11q. Eur J Hum Genet 1999; 7: B. Other publications 7. Soderpalm B, Andersson G, Enerback C, Engel JA: In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with the brain GABA (A)/benzodiazepine receptor complexes. Neurofarmacology 1997; 36(8), Engel JA, Enerback C, Fahlke C, Hulthe P, Hard E, Johannessen K, Svensson L, Soderpalm B: Serotonergic and dopaminergic involvement in ethanol intake. Novel Pharmacological interventions for alcoholism. Ed Naranjo CA, Sellers EM, Springer Verlag New York, 1992; Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, Yhr M. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133: Swanbeck G, Inerot A, Martinsson T, Enerbäck C, Enlund F, Yhr M, Wahlström J. Genetic counselling in psoriasis. Br J Dermatol.1997; 137:
2 11. Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, Yhr M. Population genetics of psoriasis: Epidemiology, causes and prevention of skin disorders. Ed Grob JJ, Blackwell Science 1997; Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson Å, Riley J, Swanbeck G, Martinsson T. Psoriasis susceptibility locus in chromosome region 3q21; identified in patients from southwestern Sweden. Eur J Hum Genet 1999; 7: Samuelsson L, Enlund F, Torinsson Å, Yhr M, Inerot A, Enerbäck C, Wahlström J, Swanbeck G, Martinsson T. A genome-wide search for genes predisposing to familial psoriasis; Results from a stratification approach. Hum Genet 1999; 105: O Brien KP, Holm SJ, Nilsson S, Carlen L, Rosenmuller T, Enerback C, Inerot A, Stahle- Backdal M. The HCR gene on 6p21 is unlikely to be a psoriasis susceptibility gene. J Invest Dermatol 2001; 116, Hewett D, Samulesson L, Polding J, Enlund F, Smart D, Cantone CG, See CG, Chadha S, Inerot A, Enerbäck C, Montgomery D, Christodolou C, Robinson P, Matthews P, Plumpton M, Dykes C, Wahlström J, Swanbeck G, Martinsson T, Roses A, Riley J, Purvis I. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 2002; mar 79(3): Enerbäck C, Porter DA, Seth P, Sgroi D, Weremowicz S, Morton CC, Schnitt S, Polyak K. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 2002; jan 1; 62(1): Martinsson H, Yhr M, Enerbäck C: Expression patterns of S100A7 (Psoriasin) and S100A9 (Calgranulin B) in keratinocyte differentiation. Exp Dermatol 2005;14(3): Carlsson H, Yhr M, Petersson S, Collins N, Polyak K, Enerbäck C: S100A7 and A100A9 induction are dependent on reactive oxygen species and are downregulated by Bcl-2 and antioxidants. Cancer Biol Ther Sep;4(9): Carlsson H, Petersson S and Enerbäck C. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development Int J Oncology 2005 Dec;27(6): Krop I, März A, Carlsson H, Li X, Qimron N, Gelman R, Schnitt S, Kleer C, Enerbäck C, Polyak K: A putative role for psoriasin in breast tumor progression. Cancer Res 2005 Dec 15;65(24): Inerot A, Enerbäck C, Enlund F, Martinsson T, Samuelsson L, Wahlström J, Swanbeck G. Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatology 2005, 5: Petersson S, Bylander A, Yhr M, Enerbäck C. S100A7 (Psoriasin), highly expressed in Ductal Carcinoma In Situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells. BMC Cancer 2007, 7:205.
3 23. Erlandson A, Appelqvist F, Wennberg AM, Holm J, Enerbäck C. Novel CDKN2A mutations detected in Western Swedish families with Hereditary Malignant Melanoma. J Invest Dermatol 2007 Jun;127: Erlandsson E, Appelqvist F, Enerbäck C: Epigenetic mutations in CDKN2A in western Swedish families with hereditary malignant melanoma. Molecular medicine reports 1: 89-91, Anderson K, Wong J, Polyak K, Aronzon D and Enerbäck C. Detection of psoriasin/s100a7 in the sera of patients with psoriasis. Br J Dermatol 2009;160(2): Petersson S, Shubbar E, Enerbäck L, Enerbäck C. Expression of S100 proteins in the progression of melanocytic lesions. Melanoma Research 2009 Aug;19(4): Carén H, Erichsen J, Enerbäck C, Olsson L, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses and MLPA for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008: 29;9: Petersson S, Shubbar E, Yhr M, Kovacs A, Enerbäck C. Loss of ICAM1 signalling induces psoriasin and MUC1 expression in mammary epithelial cells. Breast Cancer Res Treat in press. 29. Öfverholm A, Einbeigi Z, Albertsson P, Skrtic S and Enerbäck C. Association of the MDR1 C3435T variation with paclitaxel-induced neurotoxicity. Oncology letters 1: , Einbeigi Z, Enerbäck C, Karlsson P, Nordling M, Wallgren A: BRCA1 gene mutations may explain more than 80 per cent of excess number of ovarian cancer cases after breast cancer -a population based study from the Western Sweden Health region. Acta Oncol Feb Öfverholm A, Arkblad A, Skrtic S, Albertsson P, Shubbar E, Enerbäck C: Two cases of 5- fluorouracil toxicity linked with gene variants in the DPYD gene. Clin Biochem Feb;43(3): Anderson K, Petersson S, Wong J, Shubbar E, Lokko, Carlström M and Enerbäck C. Elevation of serum EGF, TNF-alpha, and IL-1Ra in active psoriasis vulgaris. Submitted. 33. Shubbar E, Nilsson J, Petersson S, Enerbäck C. Psoriasin is correlated with increased expression of VEGF, RAGE and endothelial cells proliferation. In manuscript.
4 C. Abstract 1. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Evidence that HLA-Cw6 determines early onset of psoriasis- obtained using sequence-specific-primers (PCR-SSP) / i Laugarvatn, Island : The 5th workshop of the Nordic Genome Initiative 2. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. HLA-Cw6 determines early onset of Swedish psoriatics- obtained using sequence-specific primers (PCR-SSP) 29/10-2/ i San Fransisco, USA: The American Society of Human Genetics, 46th annual meeting 3. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Betydelsen av HLA-Cw6 för debutåldern vid psoriasis. Läkarstämman, Stockholm Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Samuelsson L, Swanbeck G. Different age at onset for psoriatic siblings discordant for the presence of Cw6 at the HLA-C locus. 28/10-1/ i Baltimore, USA: The American Society of Human Genetics, 47th annual meeting. 5. Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. Cytogenetic analysis of 477 Swedish psoriasis patients. 27/10-30/ i Denver USA: The American Society of Human Genetics, 48th annual meeting. 6. Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. Cytogenetisk analys av 477 psoriasispatienter. Läkarstämman, Göteborg Enerbäck C, Staffan Nilsson, Enlund F, Inerot A, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. HLA-Cw6 is the primary association for psoriasis in the HLA region based on TDT analysis. 19/10-23/ i San Fransisco, USA: The American Society of Human Genetics, 49th annual meeting. 8. Enerbäck C: Autoreferat av avhandling. Läkarstämman Stockholm Carlsson C, Petersson S, Enerbäck C. Psoriasin induction correlate to VEGF expression. American Association for Cancer Research, AACR, Washington 1/4-5/ Petersson S, Bylander A, Enerbäck C. S100A7 (Psoriasin) is regulated by IFN-gamma in mammary epithelial cells. Advances in breast cancer research, AACR, San Diego 10-15/ Petersson S, Shubbar, Enerbäck C. Expression of S100 proteins in the progression of melanocytic lesions. European association for cancer research Lyon 5-8/ Carén H, Erichsen J, Enerbäck C, Olsson L, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses and MLPA for detection of
5 deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene. 13. Advances in breast cancer research, AACR, San Diego 10-15/
Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris
대 한 건 선 학 회 지 제 5 권, 제 1 호 Journal of the Korean Society for Psoriasis Vol. 5, No. 1, 43-47, 2008 Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris Sang Eun Lee, M.D., Jung Eun Lee,
More informationPhenotypes and Classification of Psoriasis
Rheumatology 2010 Birmingham 21 April 2010 Phenotypes and Classification of Psoriasis Christopher E.M. Griffiths Abbott Centocor Incyte Galderma Janssen-Cilag Leo Pharma Lynxx Novartis Pfizer Schering-Plough
More informationBRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS
BRCA1 and BRCA2 BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 Breast cancer is the most common cancer in women, diagnosed in
More informationtreatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can
Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods
More informationCommon Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
More informationBAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner
BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome Thomas Wiesner Disclosure Listed as co-inventor US patent application US 61/463,389 BAP1 mutational analysis in determining susceptibility
More informationA powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches
A powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches Afrouz Behboudi PhD, Associate Prof. School of Life Sciences, University
More informationHLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of
1 HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study Lotus Mallbris, MD, PhD, Katarina Wolk, MD, Fabio Sánchez
More informationProgress and Prospects in Ovarian Cancer Screening and Prevention
Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian
More informationNon Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress
Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress Lung Cancer Accounts for 14% of All New Cancer Diagnoses in the United States 1 Lung cancer is the second most common malignancy
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationHereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013
Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your
More informationpsoriasis - A New Frontier in Metastatiology
Arch Immunol Ther Exp, 2005, 53, 428 433 PL ISSN 0004-069X WWW.AITE ONLINE.ORG Review Received: 2004.12.13 Accepted: 2005.03.14 Published: 2005.10.15 Human leukocyte antigens as psoriasis inheritance and
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationCOMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
More informationMedical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011
Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: May 2015 Policy No: 02 Effective Date:
More informationGenetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2)
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationDal germinale al somatico nella identificazione di tumori ereditari
Modena 18-19 novembre 2010 Dal germinale al somatico nella identificazione di tumori ereditari Laura Ottini Tendencies to develop cancer can be inherited Fletcher & Houlston, 2010 Cancer is a genetic disease
More informationHereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel
P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t
More informationGenetics of Rheumatoid Arthritis Markey Lecture Series
Genetics of Rheumatoid Arthritis Markey Lecture Series Al Kim akim@dom.wustl.edu 2012.09.06 Overview of Rheumatoid Arthritis Rheumatoid Arthritis (RA) Autoimmune disease primarily targeting the synovium
More informationThe Human Genome Project
The Human Genome Project Brief History of the Human Genome Project Physical Chromosome Maps Genetic (or Linkage) Maps DNA Markers Sequencing and Annotating Genomic DNA What Have We learned from the HGP?
More informationGenetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service
Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How
More informationHereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center
Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary
More informationBRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010
BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations
More informationSequencing and microarrays for genome analysis: complementary rather than competing?
Sequencing and microarrays for genome analysis: complementary rather than competing? Simon Hughes, Richard Capper, Sandra Lam and Nicole Sparkes Introduction The human genome is comprised of more than
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationCollaborative Association Study of Psoriasis. Gonçalo Abecasis, Anne Bowcock, James Elder, Jerry Krueger
Collaborative Association Study of Psoriasis Gonçalo Abecasis, Anne Bowcock, James Elder, Jerry Krueger Psoriasis Chronic, inflammatory skin condition Characteristic lesions, can affect substantial proportion
More informationEfficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong
ORIGINAL ARTICLES Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong Drs. C. W. Fung, L.Y. Chong, C.Y. Leung, C. N. Look, K.K. Lo, K. M. Ho Social Hygiene Service
More informationHuman Genome Organization: An Update. Genome Organization: An Update
Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion
More informationPREPARED FOR: U.S. Army Medical Research and Materiel CommandFort Detrick, Maryland 21702 5012
AD Award Number: W81XWH 07 1 0542 TITLE: Is Nuclear Structure Altered in Breast Cancer Cells? PRINCIPAL INVESTIGATOR: Han Htun, Ph.D. CONTRACTING ORGANIZATION: University of California Los Angeles, CA
More informationH. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md
Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland
More informationInformation leaflet. Centrum voor Medische Genetica. Version 1/20150504 Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel
Information on genome-wide genetic testing Array Comparative Genomic Hybridization (array CGH) Single Nucleotide Polymorphism array (SNP array) Massive Parallel Sequencing (MPS) Version 120150504 Design
More informationAn Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip
An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip Joints Introduction Maezawa et al., have reported that
More informationAT&T Global Network Client for Windows Product Support Matrix January 29, 2015
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network
More informationTargeted Therapy in an Era of Genomic Medicine. George W. Sledge MD Stanford University
Targeted Therapy in an Era of Genomic Medicine George W. Sledge MD Stanford University Why Do Women Die of Breast Cancer? Bad biology Avoidable deaths Important subsets of breast cancers defined by molecular
More informationHeritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait
TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental
More informationOutline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice
Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary
More informationAntigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms
Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms Introduction Why does immunity to malaria take so long to develop? The parasite s survival depends on its
More informationPublikationsliste Claudia Götz
Publikationsliste Claudia Götz 1. Reinhard,B., Götz, C., and Faillard, H.: Synthesis of N-Acetyl-9-Oacetylneuraminic acid α-p-aminophenylthioketoside and its application as ligand in the affinity chromatography
More informationA Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD
A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of
More informationHER2 Status: What is the Difference Between Breast and Gastric Cancer?
Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC
More informationUnderstanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service
Understanding Hereditary Breast and Ovarian Cancer Maritime Hereditary Cancer Service General Information Cancer is very common. About one in three (33%) people are diagnosed with some form of cancer during
More informationThe Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine
The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary
More informationAutoimmunity and immunemediated. FOCiS. Lecture outline
1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationHereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center
Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt
More informationPART 3.3: MicroRNA and Cancer
BIBM 2010 Tutorial: Epigenomics and Cancer PART 3.3: MicroRNA and Cancer Dec 18, 2010 Sun Kim at Indiana University Outline of Part 3.3 Background on microrna Role of microrna in cancer MicroRNA pathway
More informationNancy E. Davidson, MD Johns Hopkins University. Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationLesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes
Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes Becoming a cancer cell isn t easy One of the fundamental molecular characteristics of cancer is that it does not develop all at once, but
More informationHAVE YOU BEEN NEWLY DIAGNOSED with DCIS?
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women
More informationHereditary diffuse gastric cancer and genetic syndromes of stomach cancer: What clinicians need to know
Hereditary diffuse gastric cancer and genetic syndromes of stomach cancer: What clinicians need to know Fátima Carneiro IPATIMUP & Medical Faculty/Centro Hospitalar São João Porto, Portugal IPATIMUP FMUP/CHSJ
More informationGuideline Development The American Society of Clinical Oncology
Assessing Genomic Sequencing Information for Health Care Decision Making Decision Making Once Evidence is Assessed/Graded Evaluated Guideline Development The American Society of Clinical Oncology Gary
More informationITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
More informationTest Information Sheet
Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence
More informationTranslocation Renal Cell Carcinomas
Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationElectronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project
1999 Oxford University Press Nucleic Acids Research, 1999, Vol. 27, No. 1 99 105 Electronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project Carol J. Bult*, Debra M. Krupke and
More informationInformation Exchange and Data Transformation (INFORMED) Initiative
Information Exchange and Data Transformation (INFORMED) Initiative Sean Khozin, MD, MPH Senior Medical Officer Office of Hematology and Oncology Products (OHOP) Food and Drug Administration (FDA) The opinions
More informationGENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP
GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT
More informationCancer: Genetic testing can save lives
Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who
More informationPublic-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC
More informationOvarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
More informationBreast cancer and the role of low penetrance alleles: a focus on ATM gene
Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1
More informationSupport Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
More informationGenome Scans For Genetic Predisposition To Alcoholism By Use Of Transmission Disequilibrium Test Analyses
Genetic Epidemiology 17(Suppl 1): S277-S281 (1999) Genome Scans For Genetic Predisposition To Alcoholism By Use Of Transmission Disequilibrium Test Analyses Grier P. Page, Terri M. King, Jill S. Barnholtz,
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationContents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer
Contents Introduction: biology and medicine, two separated compartments What we need to know: - boring basics in DNA/RNA structure and overview of particular aspects of molecular biology techniques - How
More informationUsefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers
J. Appl. Genet. 44(3), 2003, pp. 419-423 Short communication Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers Bohdan GÓRSKI,
More information6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review
Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,
More informationIdentification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany
More informationExelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference
Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/
More informationRegulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)
Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationTumour necrosis factor-a polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis
Rheumatology 2002;41:525 530 Tumour necrosis factor-a polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis A. M. Al-Heresh, J. Proctor 1,S.M.Jones,J.Dixey,B.Cox, K. Welsh 1 and N. McHugh Royal
More informationOffice of Population Health Genomics
Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation
More informationHow Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
More informationGlobally, about 9.7% of cancers in men are prostate cancers, and the risk of developing the
Chapter 5 Analysis of Prostate Cancer Association Study Data 5.1 Risk factors for Prostate Cancer Globally, about 9.7% of cancers in men are prostate cancers, and the risk of developing the disease has
More informationEffects of Herceptin on circulating tumor cells in HER2 positive early breast cancer
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
More informationFrom Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes
ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology
More informationMesothelioma. Mesothelioma and Asbestos 11/21/2009
Mesothelioma Michele Carbone, M.D.,PH.D. Director Cancer Research Center of Hawaii Professor and Chairman, Dept. of Pathology J.A. Burns Medical School University of Hawaii Honolulu, HI 96813 Mesotheliomas
More informationRisk Assessment and Screening Tools November 17, 2010
Risk Assessment and Screening Tools November 17, 2010 Cecelia Bellcross Posted in the Resource Repository at: http://www.resourcerepository.org/documents/2073/riskassessmentandscreeningtool s/ Cecelia
More informationThe EGFR mutation and precision therapy for lung cancer
for lung cancer Outcomes in advanced lung cancer have seen meaningful improvement in the past decade thanks to new precision drug therapies. Because tumors usually develop resistance to the drugs, scientists
More informationNOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES
NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or
More informationLecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)
Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur
More informationMULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist
MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.
More informationMEDICAL GENETICS GENERAL OBJECTIVE SPECIFIC OBJECTIVES
SUBJECT MEDICAL GENETICS CREDITS Total: 4.5 Theory 2.5 Practical 2 GENERAL OBJECTIVE To provide students with terminology and knowledge from the field of human genetics that will enable them to understand
More informationGenetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -
Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall
More informationForensic DNA Testing Terminology
Forensic DNA Testing Terminology ABI 310 Genetic Analyzer a capillary electrophoresis instrument used by forensic DNA laboratories to separate short tandem repeat (STR) loci on the basis of their size.
More informationM110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics
of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted
More informationTest Information Sheet
Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence
More informationJESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President
Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center
More informationHistologic Subtypes of Renal Cell Carcinoma
Histologic Subtypes of Renal Cell Carcinoma M. Scott Lucia, MD Associate Professor Chief of Genitourinary and Renal Pathology Director, Prostate Diagnostic Laboratory Dept. of Pathology University of Colorado
More informationNormal values of IGF1 and IGFBP3. Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A.
Normal values of IGF1 and IGFBP3 Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A. Agenda of the presentation IGF1 and IGFBP3 basic characteristic Why normal values Groups of the persons and
More informationMOLECULAR GENETICS OF PSORIASIS. Kati Asumalahti
HELSINKI UNIVERSITY BIOMEDICAL DISSERTATIONS, No. 27 Helsinki Biomedical Graduate School Department of Medical Genetics University of Helsinki Finland MOLECULAR GENETICS OF PSORIASIS Kati Asumalahti Academic
More informationMédecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN
Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification
More informationA23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
More informationRiesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid
Riesgo genético y familiar Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid Cancer: An example of complex disease 80-85% of cancers Polygenic model (combination of X genes) Low penetrance
More information